BioMarin Pharmaceutical (BMRN) said Friday it will acquire Amicus Therapeutics (FOLD) for $4.8 billion in a deal that adds two rare disease drugs to its portfolio. In premarket trades on the stock market today, Amicus stock catapulted 29.8% to 14.13, just under the takeover price of $14.50 per share. The biotech stock is highly rated and has climbed roughly 94%…
Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Gas prices and your...
ICICI Bank, one of India’s leading private lenders, on Saturday reported a net profit of Rs 13,702 crore in the...
It could hardly have escaped notice in the White House, and even more so in the Kremlin, that the Iran...
For all my reporting life, I’ve dreaded one question: What is the price of oil — the real one? Invariably...
The benchmark S&P 500 and the tech-heavy Nasdaq each rallied to their third record close in a row on Friday,...
Apr 17, 2026, 5:32 PM ETSPDR Gold Shares ETF (GLD), GDX, IAU, NUGT, SLVSIL, SGOL, SIVR, GDXJ, PHYS, PSLV, DUST,...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
